|
Articles that cite this article:Nasal Administration of Synthetic Acetylcholine Receptor T Epitopes Affects the Immune Response to the Acetylcholine Receptor and Prevents Experimental Myasthenia Gravisa Mapping myasthenia gravis–associated T cell epitopes on human acetylcholine receptors in HLA transgenic mice Heat-shock protein T-cell epitopes trigger a spreading regulatory control in a diversified arthritogenic T-cell response Immune response of the coeliac nasal mucosa to locally-instilled gliadin Acetylcholine receptors and myasthenia Amphipathic variable region heavy chain peptides derived from monoclonal human Wegener's anti-PR3 antibodies stimulate lymphocytes from patients with Wegener's granulomatosis and microscopic polyangiitis Reduction of human anti-tetanus toxoid antibody in hu-PBL-SCID mice by immunodominant peptides of tetanus toxoid Peptide-based therapeutic vaccines for allergic and autoimmune diseases Reactivity of T cells from women with antibodies to the human platelet antigen (HPA)-1a to peptides encompassing the HPA-1 polymorphism Peptide-based immunotherapy: a novel strategy for allergic disease Characterization of the alloreactive helper T-cell response to the platelet membrane glycoprotein IIIa (integrin-beta3) in human platelet antigen-1a alloimmunized human platelet antigen-1b1b women Vaccines against myasthenia gravis
|